Checkpoint Inhibitors in Multiple Myeloma: Intriguing Potential and Unfulfilled Promises

SIMPLE SUMMARY: Multiple myeloma (MM) is a hematological malignancy caused by aberrations in the plasma cell development, resulting in uncontrolled production of plasma cells and or monoclonal proteins. Currently, several treatments are centered around immune-based therapies including immunomodulato...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkharabsheh, Omar, Trisel, Zachary, Badami, Sunil, Aljama, Mohammed A., Sidiqi, M. Hasib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750689/
https://www.ncbi.nlm.nih.gov/pubmed/35008276
http://dx.doi.org/10.3390/cancers14010113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750689/
https://www.ncbi.nlm.nih.gov/pubmed/35008276
http://dx.doi.org/10.3390/cancers14010113

Ejemplares similares